Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Boehringer Ingelheim GmbH - SWOT Analysis'
Title Publication Date Price Relevance
Boehringer Ingelheim GmbH
Strategic Analysis Profile
 Feb 2008 £500 100%
Boehringer Ingelheim GmbH Strategic Analysis Profile Dec 2007 £500 98%
Boehringer Ingelheim GmbH
Market Share Analysis
 Sep 2010 £630 98%
Boehringer Ingelheim GmbH Market Share Analysis Sep 2010 £630 97%
Upstream Processing in Biopharmaceuticals
Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
 Mar 2011 £2,215 77%
The Pharmaceutical Market: Germany Oct 2011 £595 77%
ResMed Inc. Strategic Analysis Profile Dec 2007 £500 73%
Drug Delivery Device Market to 2017
Metered Dose Inhalers and Infusion Pumps to Be Key Revenue Generators
 Sep 2011 £2,215 67%
Anti-Inflammatory Therapeutics Market to 2017
Respiratory Diseases and Arthritis Continue to Dominate
 Oct 2011 £2,215 67%
Arthritis Therapeutics Market to 2016
Biologics Revolutionize Treatment of Rheumatoid Arthritis and Psoriatic Arthritis
 Oct 2010 £2,215 61%
Acute Coronary Syndrome (ACS) Drug Market Prospects
2011-2021
 May 2011 £1,499 60%
Sleep Disorders Market to 2017
Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market
 Apr 2011 £2,215 59%
Veterinary Vaccines Market to 2017
Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms
 Jan 2012 £2,215 56%
Sepracor Inc. Market Share Analysis Oct 2010 £630 53%
Svenska Cellulosa Aktiebolaget SCA Market Share Analysis Sep 2010 £630 50%
Botanical and Plant-Derived Drugs: Global Markets Jan 2009 £3,065 50%
GlaxoSmithKline plc Market Share Analysis Oct 2010 £630 49%
Pharmaceuticals Sep 2008 £1,235 47%
The Global Pain Therapeutics Market
4th Edition: Market Trends & R&D Insights
 Nov 2010 £1,105 41%